You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康芝藥業(300086.SZ)2020年度預盈1000萬-1500萬元 同比扭虧為盈
格隆匯 01-29 19:34

格隆匯 1 月 29日丨康芝藥業(300086.SZ)公佈,預計2020年度歸屬於上市公司股東的淨利潤1000萬元-1500萬元,上年同期虧損2646.30萬元;扣除非經常性損益後的淨利潤2000萬元-2500萬元。

公司業績與上年同期相比實現扭虧為盈,主要影響因素如下:(一)受新冠肺炎疫情影響,公司雖盡力發展與疫情防疫物資相關業務收入,2020年合併報表內的營業收入較2019年度同期相比仍有所下降。

(二)隨着2019年度新營銷策略及深化渠道發展的措施已見成效,以及2019年度對部分藥品生產子公司進行產能整合工作取得階段性成效,2020年度的銷售費用、管理費用對比2019年度同期有所減少。

()結合公司2020年度經營情況,2020所計提的資產減值損失較2019年度同期相比有所下降。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account